Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C F Leonard

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncology (Williston Park, N.Y.)|December 24, 2005
Adjuvant hormonal therapy in early breast cancerSatish Kumar, R C F Leonard
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2005
Chemotherapy for older women with early breast cancerR C F Leonard, K M Malinovszky
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2008
How age affects the biology of breast cancerG A Thomas, R C F Leonard
Expert Review of Anticancer Therapy|June 10, 2006
Treatment options for older woman with early breast cancerM Myat Moe, T Pwint Pwint, R C F Leonard
British Journal of Cancer|December 4, 2003
Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patientsR C F Leonard, D Miles, R Thomas, et al.
British Journal of Cancer|November 13, 2003
Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancerD A Cameron, C Massie, G Kerr, et al.
Breast (Edinburgh, Scotland)|August 7, 2009
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)R C F Leonard, S Williams, A Tulpule, et al.
Pediatric Blood & Cancer|October 30, 2004
A comparison of self-reported satisfaction between adolescents treated in a "teenage" unit with those treated in adult or paediatric unitsB C Reynolds, K P Windebank, R C F Leonard, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2017
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancerR A Anderson, J Mansi, R E Coleman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Capecitabine named-patient programme for patients with advanced breast cancer. the UK experienceR C F Leonard, C Twelves, J Breddy, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|December 24, 2005
Adjuvant hormonal therapy in early breast cancerSatish Kumar, R C F Leonard
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2005
Chemotherapy for older women with early breast cancerR C F Leonard, K M Malinovszky
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 17, 2008
How age affects the biology of breast cancerG A Thomas, R C F Leonard
Expert Review of Anticancer Therapy|June 10, 2006
Treatment options for older woman with early breast cancerM Myat Moe, T Pwint Pwint, R C F Leonard
British Journal of Cancer|December 4, 2003
Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patientsR C F Leonard, D Miles, R Thomas, et al.
British Journal of Cancer|November 13, 2003
Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancerD A Cameron, C Massie, G Kerr, et al.
Breast (Edinburgh, Scotland)|August 7, 2009
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)R C F Leonard, S Williams, A Tulpule, et al.
Pediatric Blood & Cancer|October 30, 2004
A comparison of self-reported satisfaction between adolescents treated in a "teenage" unit with those treated in adult or paediatric unitsB C Reynolds, K P Windebank, R C F Leonard, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2017
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancerR A Anderson, J Mansi, R E Coleman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2002
Capecitabine named-patient programme for patients with advanced breast cancer. the UK experienceR C F Leonard, C Twelves, J Breddy, et al.
Pageof 2